Polymorphisms in LMNA and near a SERPINA gene cluster are associated with cognitive function in older people

Neurobiology of Aging

Volumn 31, Issue 9, 2010, Pages 1563-1568

  Cluett, Christie ^a   Brayne, Carol ^b   Clarke, Robert ^c   Evans, Grimley ^d   Matthews, Fiona ^e   Rubinsztein, David C ^f   Huppert, Felicia ^f   Llewellyn, David J ^b   Rice, Neil ^a   Henley, William ^a   Frayling, Timothy M ^a   Murray, Anna ^a   Melzer, David ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b University Forvie Site   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e MRC BIOSTATISTICS UNIT   (United Kingdom)

^f ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

ApoE; Cognitive function; Cognitive impairment; Dementia; Gene; Late onset Alzheimer's disease; LMNA; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN E; CELL PROTEIN; DNA; LAMIN A; LAMIN C; PROTEIN SERPINA; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77954960137     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.08.020     Document Type: Article

References (32)

1. Agrelo R., Setien F., Espada J., Artiga M.J., Rodriguez M., Perez-Rosado A., Sanchez-Aguilera A., Fraga M.F., Piris M.A., Esteller M. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. J. Clin. Oncol. 2005, 23:3940-3947.
2. Araujo-Vilar D., Lado-Abeal J., Palos-Paz F., Lattanzi G., Bandin M.A., Bellido D., Dominguez-Gerpe L., Calvo C., Perez O., Ramazanova A., Martinez-Sanchez N., Victoria B., Costa-Freitas A.T. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin-resistance, aortic stenosis and hypertrophic cardiomyopathy. Clin. Endocrinol. (Oxf.) 2007.
3. Baune B.T., Ponath G., Rothermundt M., Riess O., Funke H., Berger K. Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology 2008, 33:68-76.
4. Bennett C., Crawford F., Osborne A., Diaz P., Hoyne J., Lopez R., Roques P., Duara R., Rossor M., Mullan M. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative. Am. J. Med. Genet. 1995, 60:1-6.
5. Blacker D., Haines J.L., Rodes L., Terwedow H., Go R.C., Harrell L.E., Perry R.T., Bassett S.S., Chase G., Meyers D., Albert M.S., Tanzi R. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 1997, 48:139-147.
6. Boucher D.M., Schaffer M., Deissler K., Moore C.A., Gold J.D., Burdsal C.A., Meneses J.J., Pedersen R.A., Blum M. Goosecoid expression represses Brachyury in embryonic stem cells and affects craniofacial development in chimeric mice. Int. J. Dev. Biol. 2000, 44:279-288.
7. Brayne C., Gao L., Dewey M., Matthews F.E. Dementia before death in ageing societies-the promise of prevention and the reality. PLoS Med. 2006, 3:e397.
8. Bridger J.M., Foeger N., Kill I.R., Herrmann H. The nuclear lamina. Both a structural framework and a platform for genome organization. FEBS J. 2007, 274:1354-1361.
9. Cao H., Hegele R.A. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 2000, 9:109-112.
10. Coon K.D., Myers A.J., Craig D.W., Webster J.A., Pearson J.V., Lince D.H., Zismann V.L., Beach T.G., Leung D., Bryden L., Halperin R.F., Marlowe L., Kaleem M., Walker D.G., Ravid R., Heward C.B., Rogers J., Papassotiropoulos A., Reiman E.M., Hardy J., Stephan D.A. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J. Clin. Psychiatry 2007, 68:613-618.
11. Daw E.W., Payami H., Nemens E.J., Nochlin D., Bird T.D., Schellenberg G.D., Wijsman E.M. The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet. 2000, 66:196-204.
12. Denecke J., Brune T., Feldhaus T., Robenek H., Kranz C., Auchus R.J., Agarwal A.K., Marquardt T. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS. Hum. Mutat. 2006, 27:524-531.
13. Duesing K., Charpentier G., Marre M., Tichet J., Hercberg S., Froguel P., Gibson F. Evaluating the association of common LMNA variants with type 2 diabetes and quantitative metabolic phenotypes in French Europids. Diabetologia 2008, 51:76-81.
14. Farrer L.A., Myers R.H., Connor L., Cupples L.A., Growdon J.H. Segregation analysis reveals evidence of a major gene for Alzheimer disease. Am. J. Hum. Genet. 1991, 48:1026-1033.
15. Grupe A., Abraham R., Li Y., Rowland C., Hollingworth P., Morgan A., Jehu L., Segurado R., Stone D., Schadt E., Karnoub M., Nowotny P., Tacey K., Catanese J., Sninsky J., Brayne C., Rubinsztein D., Gill M., Lawlor B., Lovestone S., Holmans P., O'Donovan M., Morris J.C., Thal L., Goate A., Owen M.J., Williams J. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum. Mol. Genet. 2007, 16:865-873.
16. Harris S.E., Fox H., Wright A.F., Hayward C., Starr J.M., Whalley L.J., Deary I.J. A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. BMC Genet. 2007, 8:43.
17. Hartwell K.A., Muir B., Reinhardt F., Carpenter A.E., Sgroi D.C., Weinberg R.A. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18969-18974.
18. Huang S., Risques R.A., Martin G.M., Rabinovitch P.S., Oshima J. Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A. Exp. Cell Res. 2008, 314:82-91.
19. McClearn G.E., Johansson B., Berg S., Pedersen N.L., Ahern F., Petrill S.A., Plomin R. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 1997, 276:1560-1563.
20. McGue M., Christensen K. The heritability of cognitive functioning in very old adults: evidence from Danish twins aged 75 years and older. Psychol. Aging 2001, 16:272-280.
21. Moir R.D., Spann T.P. The structure and function of nuclear lamins: implications for disease. Cell Mol. Life Sci. 2001, 58:1748-1757.
22. Raffaele Di Barletta M., Ricci E., Galluzzi G., Tonali P., Mora M., Morandi L., Romorini A., Voit T., Orstavik K.H., Merlini L., Trevisan C., Biancalana V., Housmanowa-Petrusewicz I., Bione S., Ricotti R., Schwartz K., Bonne G., Toniolo D. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 2000, 66:1407-1412.
23. Rao V.S., Cupples A., van Duijn C.M., Kurz A., Green R.C., Chui H., Duara R., Auerbach S.A., Volicer L., Wells J., van Broeckhoven C., Growdon J.H., Haines J.L., Farrer L.A. Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4. Am. J. Hum. Genet. 1996, 59:664-675.
24. Rubinsztein D.C., Easton D.F. Apolipoprotein E genetic variation and Alzheimer's disease: a meta-analysis. Dement. Geriatr. Cogn. Disord. 1999, 10:199-209.
25. Schaefer J.S., Zhang M. Role of maspin in tumor metastasis and angiogenesis. Curr. Mol. Med. 2003, 3:653-658.
26. Seshadri S., DeStefano A.L., Au R., Massaro J.M., Beiser A.S., Kelly-Hayes M., Kase C.S., D'Agostino R.B., Decarli C., Atwood L.D., Wolf P.A. Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study. BMC Med. Genet. 2007, 8(Suppl. 1):S15.
27. Shams T.M., Samaka R.M., Shams M.E. Maspin protein expression: a special feature of papillary thyroid carcinoma. J. Egypt Natl. Canc. Inst. 2006, 18:274-280.
28. Sharpless N.E., DePinho R.A. How stem cells age and why this makes us grow old. Nat. Rev. Mol. Cell Biol. 2007, 8:703-713.
29. Slooter A.J., Cruts M., Kalmijn S., Hofman A., Breteler M.M., Van Broeckhoven C., van Duijn C.M. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch. Neurol. 1998, 55:964-968.
30. Swan G.E., Carmelli D., Reed T., Harshfield G.A., Fabsitz R.R., Eslinger P.J. Heritability of cognitive performance in aging twins. The National Heart, Lung, and Blood Institute Twin Study. Arch. Neurol. 1990, 47:259-262.
31. Yaffe K., Lindquist K., Sen S., Cauley J., Ferrell R., Penninx B., Harris T., Li R., Cummings S.R. Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study. Neurobiol. Aging 2007.
32. Yip A.G., Brayne C., Easton D., Rubinsztein D.C. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population. J. Med. Genet. 2002, 39:639-643.